Latest results from the UK trials evaluating prostate cancer screening and treatment: the CAP and ProtecT studies. Eur J Cancer 2010; 46 :3095-101.Lane JA, Hamdy FC, Martin RM, Turner EL, Neal DE, Donovan JL. Latest results from the UK trials evaluating prostate cancer screening and ...
Is screening--an important means of cancer control for many sites--a reasonable approach for prostate cancer control? The answer is not straightforward because prostate cancer is not one, but three diseases: a latent form which will cause no harm; a progressive form which will become symptomatic...
Up to date, screening for prostate cancer (PCa) remains one of the most appealing but also a very controversial topics in the urological community. PCa is the second most common cancer in men worldwide and it is universally acknowledged as a complex disease, with a multi-factorial etiology. ...
and The Urology Foundation during the conduct of the study and grants and personal fees from Sophiris Biocorp, Sonacare Inc, and Boston Scientific (previously Galil and BTG) and grants from Trod Medical, Prostate Cancer UK Charity, MRC (UK), Cancer Research UK, and Imperial Health Charity out...
Prostate-Specific Antigen–Based Screening for Prostate Cancer: A Systematic Evidence Review for the US Preventive Services Task Force: Evidence Synthesis No. 154. Rockville, MD: Agency for Healthcare Research and Quality; 2018. AHRQ publication 17-05229-EF-1. 4. Fenton JJ, Weyrich MS, Durbin ...
UK trial (CaP), MartinPSA, cutoff 3ng/mL, single screenCluster-randomized with 189,386 men in the screening and 219,439 men in the control arm, ages 50–69, units 573 primary care practices10yearsRR 0.96, 95% CI 0.85–1.08 (3.0 vs. 3.1 per 10,000 person-years) ...
While grabbing groceries at Food Bank for New York City in Harlem, Glendon Cooper got even more than he came for; within minutes, he was in the hands of health care workers, getting screened for prostate cancer in the Mount Sinai Robert F. Smith Mobile Prostate Cancer Screening Unit. ...
prostate cancer. The test is not recommended for healthy men, however, because high PSA levels are not always indicative of prostate cancer. Indeed, research has shown that in many cases PSA screening may suggest only the presence of an infection, abenignenlarged prostate, or a small slow-...
Chicago—The controversy swirling around the appropriateness of screening for prostate cancer may have become even more controversial.At the annual meeting
Prostate canceris the most common cancer in men in the UK (Cancer Research UK) and the number ofprostate cancer diagnosesis set to increase in the future largely due to improvements in detection (Maddams et al., 2012). Over the last ten years the treatment of prostate cancer has changed ...